In vitro activities of five quinolones against Chlamydia pneumoniae.

AUTOR(ES)

Hammerschlag, M R

RESUMO

The in vitro susceptibilities of 10 strains of Chlamydia pneumoniae were determined for five quinolones, including ciprofloxacin, ofloxacin, fleroxacin, temafloxacin, and sparfloxacin. Sparfloxacin was the most active compound tested, followed by ofloxacin and temafloxacin. Ciprofloxacin and fleroxacin were the least active. The use of HEp-2 cells for testing C. pneumoniae resulted in larger inclusions but essentially the same endpoints as were seen with use of HeLa 229 cells.

Documentos Relacionados

• In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae.
• In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae.
• In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
• In vitro activity of trovafloxacin against Chlamydia pneumoniae.
• In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae.